Answers are grounded in this paper and cite their sources.
Voriconazole (VC), a second-generation triazole antifungal, suffers from low aqueous solubility (∼0.5 mg mL −1 ), which restricts its oral bioavailability.
No takes yet. Share an insight, caveat, or question.
Daravath et al. (2025) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: